AXIM Biotechnologies: Sergei Svarovsky

AXIM Biotechnologies has appointed Sergei Svarovsky as the CSO of subsidiary Sapphire Biotech. Svarovsky previously served as a research fellow at the National Institute of Health's National Cancer Institute. AXIM noted that Svarovsky has experience with cancer drug design medical diagnostics develompent, including developing a wide range of biological assays for existing and novel platforms for many well-known biotech firms.